Skip to main content
Equibles

Swiss National Bank

Bank

Position in HIMS — Hims & Hers Health, Inc.

CIK 1582202 ZURICH, V8
Back to HIMS Full portfolio

Position in HIMS

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$13,750,122
+$5,643,342 QoQ
Shares Held
396,600
+1.6% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#54
of 507 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. HIMS ranks #9 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 4,121,700 $139,643,196
2 ZTS
Zoetis Inc.
 1,186,032 $85,228,259
3 UTHR
UNITED THERAPEUTICS Corp
 111,255 $60,281,296
4 NBIX
Neurocrine Biosciences Inc
 268,900 $45,320,406
5 VTRS
Viatris Inc
 2,336,402 $37,102,063
6 ELAN
Elanco Animal Health Inc
 1,001,992 $24,659,023
7 ALKS
Alkermes plc.
 316,900 $16,605,560
8 LNTH
Lantheus Holdings, Inc.
 130,654 $14,494,754

All Filings in HIMS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,750,122 396,600
2026-03-31 $8,106,780 390,500
2025-12-31 $12,539,914 386,200
2025-09-30 $21,326,720 376,000
2025-06-30 $17,307,920 347,200
2025-03-31 $10,224,300 346,000
2024-12-31 $8,409,804 347,800
2024-09-30 $5,194,440 282,000
2024-06-30 $5,723,865 283,500
2024-03-31 $4,354,805 281,500
2023-12-31 $2,487,550 279,500
2023-09-30 $1,944,868 309,200
2023-06-30 $2,661,140 283,100
2023-03-31 $2,561,344 258,200
2022-12-31 $1,845,439 287,900
2022-09-30 $1,569,654 281,300
2022-06-30 $1,258,434 277,800
2022-03-31 $986,050 185,000
2021-12-31 $1,123,325 171,500
2021-09-30 $1,216,202 161,300
2021-06-30 $1,756,557 161,300